Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1734-1740

  Miyata, Yasuyoshi ^a   Koga, Shigehiko ^a   Takehara, Kousuke ^a   Kanetake, Hiroshi ^a   Kanda, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4N1K PEPTIDE; ANTIBODY; LYSYLARGINYLPHENYLALANYLVALYLVALYLMETHIONYLTRYPTOPHYLLYSYLLYSYLANINE; PEPTIDE; STROMELYSIN; THROMBOSPONDIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STAINING; TUMOR ANGIOGENESIS; TUMOR GROWTH;

ADULT; AGED; APOPTOSIS; CARCINOMA, RENAL CELL; CELL DIVISION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 0012174831     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lawler, J. The function of thrombospondin-1 and -2. Curr. Opin. Cell Biol., 12: 634-640, 2000.
2. Bornstein, P. Thrombospondins as matricellular modulators of cell function. J. Clin. Investig., 107: 929-934, 2001.
3. Roberts, D. D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J., 10: 1183-1191, 1996.
4. Tuszynski, G. P., and Nicosia, R. F. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays, 18: 71-76, 1996.
5. Fraipont, F., Nicholson, A. C., Feig, J-J., and Van Meir, E. G. Thrombospondins and tumor angiogenesis. Trend Mol. Med., 7: 401- 407, 2001.
6. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. P. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol., 122: 497-511, 1993.
7. Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Fraizer, W. A., and Bouck, N. P. CD 36 mediates the in vitro inhibitory effect of thrombospondin-1 on endothelial cells. J. Cell Biol., 138: 707-717, 1997.
8. Guo, N-H., Krutzsch, H. C., Inman, J. K., and Robert, D. D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induced apoptosis of endothelial cells. Cancer Res., 57: 1735-1742, 1997.
9. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Robert, D. D., and Murphy-Ullrich, J. E. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem., 270: 7304-7310, 1995.
10. Greenwood, J. A., Pallero, M. A., Theibert, A. B., and Murphy-Ullrich, J. E. Thrombospondin signaling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase. J. Biol. Chem., 273: 1755-1763, 1998.
11. 1 integrin modulates endothelial cell responses to thrombospondin-1. Mol. Biol. Cell, 11: 2885-2900, 2000.
12. Gao, A-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., and Frazier, W. A. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem., 271: 21-24, 1996.
13. i-mediated inhibition of adenylate cyclase and extracellular-regulated kinases. J. Cell Biol., 147: 389-400, 1999.
14. 3 function through integrin-associated protein. J. Cell Biol., 135: 533-544, 1996.
15. Kanda, S., Shono, T., Tomasini-Johansson, B., Klint, P., and Saito, Y. Role of thorombospondin-1-derived peptide, 4N1K, in FGF-1-induced angiogenesis. Exp. Cell Res., 252: 262-272, 1999.
16. Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J. J., Chen, H., Mosher, D. F., and Bouck, N. Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun., 217: 326-332, 1995.
17. Kyriakides, T. R., Zhu, Y. H., Smith, L. T., Bain, S. D., and Bornstein, P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol., 140: 419-430, 1998.
18. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P., O'Sullivan, B., Sobin, L. H., and Yarbro, J. W. American Joint Committee on Cancer. Manual for Staging of Cancer. Philadelphia: Lippincott-Raven, 1997.
19. Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., Bochner, B. H., Esrig, D., Groshen, S., Dunn, M., Nichols, P. W., Taylor, C. R., Skinner, D. G., and Cote, R. J. Thrombospondin-1 expression in bladder cancer: association with P53 alterations, tumor angiogenesis, and tumor progression. J. Natl. Cancer Inst. (Bethesda), 89: 219-227, 1997.
20. Kitagawa, Y., Kunimi, K., Uchibayashi, T., Sato, H., and Namiki, M. Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J. Urol., 162 (Part 1): 905-909, 1992.
21. Mehta, R., Kyshtoobayeva, A., Kurosaki, T., Small, E. J., Kim, H., Stroup, R., McLaren, C. E., Li, K-T., and Fruehauf, J. P. Independent association of angiogenesis index with outcome in prostate cancer. Clin. Cancer Res., 7: 81-88, 2001.
22. Seki, N., Kodama, J., Hashimoto, I., Hongo, A., Yoshinouchi, M., and Kudo, T. Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis. Int. J. Oncol., 19: 305-310, 2001.
23. Kawahara, N., Ono, M., Taguchi, K., Okamoto, M., Shimada, M., Takenaka, K., Hayashi, K., Mosher, D. F., Sugimachi, K., Tsuneyoshi, M., and Kuwano, M. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology, 28: 1512-1517, 1998.
24. Oshika, Y., Masuda, K., Tokunaga, T., Hatanaka, H., Kamiya, T., Abe, Y., Ozeki, Y., Kijima, H., Yamazaki, H., Tomaoki, N., Ueyama, Y., and Nakamura, M. Thrombospondin-2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin. Cancer Res., 4: 1785-1788, 1998.
25. Maeda, K., Nishiguchi, Y., Kang, S. M., Yashiro, M., Onoda, N., Sawada, T., Ishikawa, T., and Hirakawa, K. Expression of thromospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol. Rep., 8: 763-766, 2001.
26. Kasper, H. U., Ebert, M., Malfertheiner, P., Roessner, A., Kirkpatrick, C. J., and Wolf, H. K. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density. Virchows Arch., 438: 116-120, 2001.